Page last updated: 2024-11-02

oxybutynin and Bradykinesia

oxybutynin has been researched along with Bradykinesia in 1 studies

oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.

Research Excerpts

ExcerptRelevanceReference
"Nocturnal hypokinesia is a common symptom in Parkinson's disease (PD), negatively affecting quality of life of both patients and caregivers."2.84Rotigotine for nocturnal hypokinesia in Parkinson's disease: Quantitative analysis of efficacy from a randomized, placebo-controlled trial using an axial inertial sensor. ( Anan, C; Bhidayasiri, R; Boonpang, K; Chaiwong, S; Jagota, P; Leaknok, A; Penkeaw, N; Rattanachaisit, W; Saksornchai, K; Sringean, J; Thanawattano, C, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bhidayasiri, R1
Sringean, J1
Chaiwong, S1
Anan, C1
Penkeaw, N1
Leaknok, A1
Boonpang, K1
Saksornchai, K1
Rattanachaisit, W1
Thanawattano, C1
Jagota, P1

Trials

1 trial available for oxybutynin and Bradykinesia

ArticleYear
Rotigotine for nocturnal hypokinesia in Parkinson's disease: Quantitative analysis of efficacy from a randomized, placebo-controlled trial using an axial inertial sensor.
    Parkinsonism & related disorders, 2017, Volume: 44

    Topics: Accelerometry; Aged; Dopamine Agonists; Female; Humans; Hypokinesia; Male; Middle Aged; Parkinson Di

2017